23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Preventative speciality can diagnose rare and inherited health conditions but difficulty accessing the service is affecting ...

Customers of Atlas Biomed are angry and worried about what's happened to the highly sensitive data they shared.

Jessica Ko saw others sharing their DNA results online and decided to take a test. The results have changed how she sees ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...